Biochem - Company Profile

Products

BioChem Solutions holds the global master license to produce and market medicines derived from the patented products Trioxolane and Diperoxide, specifically targeting viral, fungal, bacterial and protozoal diseases and health conditions. The company's lead therapeutics are Alphamir, a prescription-only medicine to combat HIV/AIDS, and Arthromir, for patients suffering from rheumatoid arthritis. Each of these products utilize Trioxolane derivatives which, when administered to patients, produce high-energy oxygen metabolites within the blood stream, causing a respiratory burst and activating certain receptor cells in the oropharyngeal cavity. In turn, those receptor cells hasten patients' natural production CD4 cells, precursor cells to lymphocytes, which support and modulate the natural immune system.

Trioxolane

Alphamir Data

Arthromir Data

Safety Profile

Respiratory Burst

In May 2001, the company obtained provisional registration from the Republic of Kenya for use of Alphamir and Arthromir. These approvals were issued following initial clinical trials at the Kenya Medical Research Institute (KEMRI), the federal agency responsible for all health-science research in that African nation. Updated clinical data was submitted in May 2002, which allowed expanded use of the two medicines as ethical drugs in 28 sub-Saharan African countries that are members of the East African Medical Conference.

In October 2007, BioChem Solutions entered in to a sub-license agreement with Molecular Technologies Ltd. in Nairobi, Kenya. The Kenyan government granted Molecular Technologies an extension of BioChem Solutions' provisional registrations, which authorizes continuing Phase 3 clinical trials of both medicines.

Additionally, protocols are now completed to begin trials at KEMRI for the new product Prophamir, a contraceptive vaginal gel intended to prevent the transmission of HIV/AIDS.

BioChem Solutions' products have potential in destroying tumor cells and harmful micro-organisms such as bacteria, viruses and parasites. Treatments are non-toxic and have shown no adverse side effects.


Home \| Company \| Products \| Development \| Media \| Contact Us